Clinical Trials Browser

Phase 2 × Lymphohistiocytosis, Hemophagocytic × Gemcitabine × Clear all

NCT04405375 2020-05-28

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

Phase 2 Unknown

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell